2-amino-5-benzoylthiazole npy antagonists

1. Compounds of formula IgdeRoznachaet amino, aryl or heteroaryl, is hydrogen or alkyl, is hydrogen, alkyl or halogen; R-alkyl or halogen, is hydrogen, alkyl or halogen, a is 0 or 1, ab is 0, 1 or 2 and their pharmaceutically acceptable salts and esters efiry.2. Compounds according to claim 1, wherein R vodorod.3. Compounds according to claim 1, wherein R vodorod.4. Compounds according to claim 1, wherein R alkil.5. Compounds according to claim 4, wherein R metil.6. Compounds according to claim 1, wherein R vodorod.7. Compounds according to claim 1, wherein b is equal to 0.8. Compounds according to claim 1, wherein a is 0.9. Compounds according to claim 1, wherein a is 1.10. Compounds according to claim 1, wherein R monoalkylamino, dialkylamino, phenyl, thiophenyl or pyrrolidinyl, wherein phenyl, thiophenyl and pyrrolidinyl are optionally substituted with one to three substituents independently selected from the group consisting of alkyl, halogen, alkoxy, trifluoromethoxy, nitro and triftormetil.11. Compounds according to claim 10, wherein R thiophen-3-yl, 3-fluorophenyl, 4-fluorophenyl, 2-methylphenyl, 2-methoxy-5-methylphenyl, dimethylamino, thiophene-2-yl, 5-fluoro-2-methylphenyl, 2,4-difluorophenyl, 5-chloro-2-methoxyphenyl, 2-fluorophenyl, 3-fluorophenyl, 2-chloro-5-trifluoromethylphenyl, 3-nitrophenyl, 4-nitrophenyl or 4-metoksifenil.12. Compounds according to claim 1, selected from the group consisting of {4- [5- (2-methylbenzoyl) thiazol-2-ylamino] -phenyl} -amide thiophene-2-sulfonic acid {4- [5- (2-methylbenzoyl) -thiazol -2-ylamino] -phenyl} -amide thiophene-3-sulfonic acid, 5- {4- [5- (2-methylbenzoyl) thiazol-2-ylamino] -phenyl} -amide chlorothiophene-2-sulfonic acid, 2-fluoro-N- {4- [5- (2-methylbenzoyl) thiazol-2-ylamino] -phenyl} -benzenesulfonamide, 3-fluoro-N- {4- [5- (2-methylbenzoyl) thiazol-2-ylamino] -phenyl} -benzenesulfonamide,